Skip to main content

Advertisement

Log in

In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls [1]

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

We have examined bone cells derived from iliac crest trabecular explants of 30 patients with idiopathic osteoporosis and 45 control subjects in order to determine whether intrinsic abnormalities in osteoblast function may contribute to the decreased bone formation observed in this disease. Bone cells isolated from all subjects expressed several in vitro characteristics of the osteoblast phenotype including adenylate cyclase responsiveness to parathyroid hormone (PTH) and prostaglandin E1 (PGE1), basal and 1,25(OH)2D3-stimulated alkaline phosphatase activity and osteocalcin production. Results were compared amongst three subject groups: young controls less than 40 years old, older controls over 40 years old, and osteoporotics. Osteoporotic cells were found in general to be fully active in vitro. There were no differences between osteoporotic and control cells in their basal levels of adenylate cyclase, or alkaline phosphatase, in their growth rates, or cell morphology. The cyclic AMP (cAMP) response to PTH was significantly lower in osteoporotic cells (71%,p<0.01) and older control cells (64% ,p<0.005) relative to the response in cells from younger controls, suggesting that the decreased responsiveness in osteoporotic cells was due to subject age rather than the osteoporotic state. At the same time, the cAMP responses to PGE1 and cholera toxin were similar in cells from all three subject groups. The response to forskolin was reduced to about 40% in osteoporotic cells compared with controls, but this was not mirrored by similar differences in the responses to PTH, PGE1 or cholera toxin, suggesting that the availability of catalytic subunits is not rate-limiting in these cells. l,25 (OH)2D3-stimulated osteocalcin production was 220% higher in osteoporotics than in older controls, but the numbers tested were small and the difference did not reach significance. The one significant abnormality we observed in osteoporotic cells was in alkaline phosphatase activity: 1,25(OH)2D3-stimulated alkaline phosphatase activity was twofold higher in osteoporotics than in younger (p<0.05), older (p<0.05) and pooled controls (p<0.025). The significance of this finding is unknown, but we postulate that it may reflect an intrinsic abnormality in osteoblast function in patients with idiopathic osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wong MM, LY H, Rao LG, Hamilton L, Ish-Shalom S, Sturtridge W, Tong J, Transfeldt E, Murray TM. In vitro study of osteoblast-like cells from patients with idiopathic osteoporosis: preliminary observations on hormonal responses and growth rates. In: Christiansen C, Johansen SJ, Riis BJ, editors. Osteoporosis 1987. Copenhagen: Osteopress ApS, 1987:234–6.

    Google Scholar 

  2. Darby AJ, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis. Calcif Tiss Int 1981 ;33:199–204.

    CAS  Google Scholar 

  3. Arlot M, Edouard C, Meunier PJ, Neer RM, Reeve J. Impaired osteoblast function in osteoporosis: comparisons between calcium balance and dynamic histomorphometry. BMJ 1984;289:517–20.

    CAS  PubMed  Google Scholar 

  4. Parfitt AM, Shih M-S, Rao DS, Kleerekoper M. Relationship between bone formation rate and osteoblast surface in aging and osteoporosis: evidence for impaired osteoblast recruitment in pathogenesis. J Bone Miner Res 1992; 7 (Suppl 1): abstr 94.

    Google Scholar 

  5. Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor alpha: lack of regulation by 17 beta-estradiol. Endocrinology 1992;130:2528–34.

    Article  CAS  PubMed  Google Scholar 

  6. Khokher MA, Dandona P. Fluopride stimulates [3H]thymidine incorporation and alkaline phosphatase production by human osteoblasts. Metabolism 1990;39:1118–21.

    Article  CAS  PubMed  Google Scholar 

  7. Beresford JN, Fedarko NS, Fisher LW, Midura RJ, Yanagoshita M, Termine JD, Robey PG. Analysis of the proteoglycans synthesized by human bone cells in vitro. J Biol Chem 1987;262:17164–72.

    CAS  PubMed  Google Scholar 

  8. Johanson JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992;7:501–12.

    Google Scholar 

  9. Wong MM, Rao LG, Hao Ly, Hamilton L, Tong J, Sturtridge W, McBroom R, Aubin JE, Murray TM. Long-term effects of physiological concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res 1990;5:803–13.

    CAS  PubMed  Google Scholar 

  10. Mills BG, Singer FR, Weiner LP, Holst PA. Cell cultures from bone affected by Paget's disease. Arthritis Rheum 1980;23:1115–20.

    CAS  PubMed  Google Scholar 

  11. Silve C, Grosse B, Tau C, Garabedian M, Fritsch J, Delmas PD, Cournot-Witmer G, Balsan S. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development. J Clin Endocrinol Metab 1986;62:583–90.

    CAS  PubMed  Google Scholar 

  12. Marie PJ, Lomri A, de Vernejoul MC, Morieux C, Graulet A-M, Gueris J, Llach F. Relationship between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy. J Clin Endocrinol Metab 1989;69:1166–73.

    CAS  PubMed  Google Scholar 

  13. Murray TM, Rao LG, Wong MM, Waddell JP, McBroom R, Tam CS, Rosen F, Levin MA. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res 1993;8:83–91.

    CAS  PubMed  Google Scholar 

  14. Ish-Shalom S, Josse RG, Wong M, Rao LG, Fraser D, Kooh SW, Murray TM. Responsiveness to parathyroid hormone, forskolin (F) and cholera toxin (CTX) of bone-derived cells from a patient with pseudohypoparathyroidism (PHP) Type IA. In: 69th Annual Meeting of the Endocrine Society, 1987: abstr 554.

  15. Marie PJ, Sabbagh A, de Vernejoul M-C, Lomri A. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Meta 1989;69:272–9.

    CAS  Google Scholar 

  16. Lomri A, Marie P. Bone cell responsiveness to transforming growth factor B, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women. J Bone Miner Res 1990;5:1149–55.

    CAS  PubMed  Google Scholar 

  17. Dodds RA, Emery RJH, Klenerman L, Chayen J, Bitensky L. Selective depression of metabolic activities in cortical osteoblasts at the site of femoral neck fractures. Bone 1990;11:157–61.

    Article  CAS  PubMed  Google Scholar 

  18. Marie PJ, de Vernejoul MC, Connes D, Hott M. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J Clin Invest 1991;88:1167.

    CAS  PubMed  Google Scholar 

  19. Murray TM, Harrison JE, Bayley TA, Josse RG, Sturtridge WC, Chow R, Budden F, Lauries L, Pritzker KPH, Kandel R, Vieth R, Strauss A, Goowin S. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response. J Bone Miner Res 1990;5 (Suppl 1):S27-S35.

    PubMed  Google Scholar 

  20. Harrison JE, McNeill KG, Hitchman AJW, Britt BA. Bone mineral measurements of the central skeleton by in vivo neutron activation analysis for routine investigation of osteopenia. Invest Radiol 1979;14:27–34.

    CAS  PubMed  Google Scholar 

  21. Beresford JN, Gallagher JA, Gowan M, McGuire MKB, Poser J. Human bone cells in culture: a novel system for the investigation of bone cell metabolism. Clin Sci 1983;64:38–9.

    Google Scholar 

  22. Shimizu H, Daley JW, Creveling CE. A radioisotopic method for measuring the formation of adenosine 3′,5′-cycIic monophos-phate in incubated slices of brain. J Neurochem 1969;16:1609–19.

    CAS  PubMed  Google Scholar 

  23. Salomon Y. Adenylate cyclase assay. Adv Cyclic Nucleotide Res 1979;10:35–55.

    CAS  PubMed  Google Scholar 

  24. Lowry OH. Micromethods for the assay of enzyme. II. Specific procedures: alkaline phosphatase. Methods Enzymol 1955;4:371–2.

    Google Scholar 

  25. Price PA, Nishimoto SK. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 1980;77:2234–8.

    CAS  PubMed  Google Scholar 

  26. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 162;194:495–6.

  27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75.

    CAS  PubMed  Google Scholar 

  28. Hayflick L. Subculturing human diploid fibroblast cultures. In: Kruse PF Jr, Patterson MK Jr, editors. Tissue culture: methods and applications. New York: Academic Press, 1973:220–3.

    Google Scholar 

  29. Aurbach GD, Potts JT Jr. Partition of parathyroid hormone on Sephadex G-100. Endocrinology 1964;75:290–4.

    CAS  PubMed  Google Scholar 

  30. Riggs BL, Melton LJ III. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983;75:899–901.

    Article  CAS  PubMed  Google Scholar 

  31. Crisp AJ, McQuire-Goldring MB, Goldring SR. A system for culture of human trabecular bone and hormone response profile of derived cells. Br J Exp Pathol 1984;65:645–54.

    CAS  PubMed  Google Scholar 

  32. Chavassieux PM, Chenu C, Valentin-Opran A, Merle B, Delmas PD, Hartmann DJ, Saez S, Meunier PJ. Influence of experimental conditions on osteoblast activity in human primary bone cultures. J Bone Miner Res 1990;5:337–43.

    CAS  PubMed  Google Scholar 

  33. Rodan GA. Autocrine/paracrine regulation of osteoblast growth and differentiation [editorial]. Lab Invest 1991;64:593–5.

    CAS  PubMed  Google Scholar 

  34. Koshihara Y, Kawamura M, Endo S, Tsutsumi C, Kodama H, Oda H, Higaki S. Establishment of human osteoblastic cells derived from periosteum in culture. In Vitro 1989;25:37.

    CAS  Google Scholar 

  35. Evans CE, Galasko CSB, Ward C. Effect of donor age on the growth in vitro of cells obtained from human trabecular bone. J Orthop Res 1990;8:234–7.

    Article  CAS  PubMed  Google Scholar 

  36. Duda RJ Jr, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL. Concurrent assays of circulating bone gla-protein and bone alkaline phosphatase: effects of sex, age and metabolic bone disease. J Clin Endocrinol Metab 1988;66:951–7.

    CAS  PubMed  Google Scholar 

  37. Koshihara Y, Hirano M, Kawamura M, Oda H, Higaki S. Mineralization ability of cultured human osteoblast-like periosteal cells does not decline with aging. J Gerontol 1991;46:B201-B6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, M.M., Rao, L.G., Ly, H. et al. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls [1]. Osteoporosis Int 4, 21–31 (1994). https://doi.org/10.1007/BF02352257

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02352257

Keywords

Navigation